FDA 483 - Abbott Laboratories Inc. - March 29, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Abbott Laboratories Inc. in Casa Grande, AZ, received a Form 483 citing significant issues in infant formula manufacturing. The inspection revealed a lack of adequate process controls to prevent microbial contamination, particularly Cronobacter sakazakii, stemming from environmental monitoring failures, persistent water leaks, and poor transition zone hygiene. Additionally, the firm failed to maintain sanitary building conditions and lacked proper equipment monitoring to prevent metal contamination in finished products.
ID · af83741c-4745-4a96-9860-37c5bc5eb43d